BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jiang Y, Han QJ, Zhang J. Hepatocellular carcinoma: Mechanisms of progression and immunotherapy. World J Gastroenterol 2019; 25(25): 3151-3167 [PMID: 31333308 DOI: 10.3748/wjg.v25.i25.3151]
URL: https://www.wjgnet.com/1007-9327/full/v25/i25/3151.htm
Number Citing Articles
1
Firoz A. Dain Md Opo, Mohammed M. Rahman, Foysal Ahammad, Istiak Ahmed, Mohiuddin Ahmed Bhuiyan, Abdullah M. Asiri. Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP proteinScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83626-x
2
Maya S. Krishnan, Anand Rajan KD, Jangho Park, Vinodhini Arjunan, Fernando Jose Garcia Marques, Abel Bermudez, Olivia A. Girvan, Nam S. Hoang, Jun Yin, Mindie H. Nguyen, Nishita Kothary, Sharon Pitteri, Dean W. Felsher, Renumathy Dhanasekaran. Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive BiomarkersHepatology 2021; 73(6): 2342 doi: 10.1002/hep.31614
3
Tianbing Wang, Bang Chen, Tao Meng, Zhiqiang Liu, Wenyong Wu. Identification and immunoprofiling of key prognostic genes in the tumor microenvironment of hepatocellular carcinomaBioengineered 2021; 12(1): 1555 doi: 10.1080/21655979.2021.1918538
4
Ji-An You, Yuhan Gong, Yongzhe Wu, Libo Jin, Qingjia Chi, Da Sun. WGCNA, LASSO and SVM Algorithm Revealed RAC1 Correlated M0 Macrophage and the Risk Score to Predict the Survival of Hepatocellular Carcinoma PatientsFrontiers in Genetics 2022; 12 doi: 10.3389/fgene.2021.730920
5
Chun Chen, Yanqiu Gu, Rong Wang, Xinyi Chai, Shuya Jiang, Shaozhan Wang, Zhenyu Zhu, Xiaofei Chen, Yongfang Yuan. Comparative two-dimensional GPC3 overexpressing SK-Hep1 cell membrane chromatography /C18/ time-of-flight mass spectrometry for screening selective GPC3 inhibitor components from Scutellariae RadixJournal of Chromatography B 2021; 1163: 122492 doi: 10.1016/j.jchromb.2020.122492
6
A. Yu. Goryainova, A. I. Stukan, R. A. Murashko, S. V. Sharov, O. I. Kirsanova, E. V. Lymar. Efficacy of the immune checkpoint inhibitor nivolumab in the treatment of advanced hepatocellular carcinoma with the exhausted possibilities of therapy with tyrosine kinase inhibitorsMeditsinskiy sovet = Medical Council 2021; (20): 84 doi: 10.21518/2079-701X-2021-20-84-93
7
Patrizia Leone, Antonio Giovanni Solimando, Rossella Fasano, Antonella Argentiero, Eleonora Malerba, Alessio Buonavoglia, Luigi Giovanni Lupo, Valli De Re, Nicola Silvestris, Vito Racanelli. The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma TreatmentVaccines 2021; 9(5): 532 doi: 10.3390/vaccines9050532
8
Hao Xu, Chen Xiong, Yuan Chen, Chi Zhang, Dousheng Bai. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinomaBioengineered 2021; 12(1): 2664 doi: 10.1080/21655979.2021.1938470
9
Jiaheng Xie, Liang Chen, Qingmei Sun, Haobo Li, Wei Wei, Dan Wu, Yiming Hu, Zhechen Zhu, Jingping Shi, Ming Wang. An immune subtype-related prognostic signature of hepatocellular carcinoma based on single-cell sequencing analysisAging 2022; 14(7): 3276 doi: 10.18632/aging.204012
10
Baohui Zhang, Bufu Tang, Jiarui Lv, Jianyao Gao, Ling Qin. Systematic analyses to explore immune gene sets-based signature in hepatocellular carcinoma, in which IGF2BP3 contributes to tumor progressionClinical Immunology 2022; 241: 109073 doi: 10.1016/j.clim.2022.109073
11
Xinchen Tian, Tinghao Yan, Fen Liu, Qingbin Liu, Jing Zhao, Huabao Xiong, Shulong Jiang. Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insightsFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.991052
12
Lin Sun, Luwen Mu, Jing Zhou, Wenjie Tang, Linqi Zhang, Sidong Xie, Jingbiao Chen, Jin Wang. Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinomaCancer Immunology, Immunotherapy 2022; 71(1): 25 doi: 10.1007/s00262-021-02957-w
13
Ola M. S. Khedr, Sawsan M. El-Sonbaty, Fatma S. M. Moawed, Eman I. Kandil, Basma E. Abdel-Maksoud. Lactobacillus acidophilus ATCC 4356 Exopolysaccharides Suppresses Mediators of Inflammation through the Inhibition of TLR2/STAT-3/P38-MAPK Pathway in DEN-Induced Hepatocarcinogenesis in RatsNutrition and Cancer 2022; 74(3): 1037 doi: 10.1080/01635581.2021.1934490
14
Mihai Ceausu, Bogdan Socea, Dragos Serban, Cătălin   Smarandache, Dragoş Predescu, Nicolae Bacalbaşa, Iulian Slavu, Adrian  Tulin, Lucian Alecu, Zenaida Ceauşu. Heterogeneity of antigenic constellation in human hepatocellular carcinomaExperimental and Therapeutic Medicine 2021; 21(3) doi: 10.3892/etm.2021.9701
15
Jing Liu, Tongyu Liu, Chuanhao Zhang, Jiabei He, Dong Zhou, Zhe Wang, Ruoyu Wang. EIF2S2 is a novel independent prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinomaFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.992343
16
Chaohui Liu, Jiansheng Pan, Hongyu Liu, Rongkai Lin, Yijie Chen, Chenghua Zhang. Daphnetin inhibits the survival of hepatocellular carcinoma cells through regulating Wnt/β‐catenin signaling pathwayDrug Development Research 2022; 83(4): 952 doi: 10.1002/ddr.21920
17
Yalei Zhao, Chen Xue, Zhongyang Xie, Xiaoxi Ouyang, Lanjuan Li. Comprehensive analysis of ubiquitin‐specific protease 1 reveals its importance in hepatocellular carcinomaCell Proliferation 2020; 53(10) doi: 10.1111/cpr.12908
18
Muhammed Mehdi Üremiş, Nuray Üremiş, Emir Tosun, Merve Durhan, Yılmaz Çiğremiş, Ahmet Baysar, Yusuf Türköz. Cucurbitacin D Inhibits the Proliferation of HepG2 Cells and Induces Apoptosis by Modulating JAK/STAT3, PI3K/Akt/mTOR and MAPK Signaling PathwaysCurrent Cancer Drug Targets 2022; 22(11): 931 doi: 10.2174/1568009622666220623141158
19
Janis M. Lapsley, Vincent Wavreille, Sabrina Barry, Josephine A. Dornbusch, Carolyn Chen, Haley Leeper, Judith Bertran, Diane Scavelli, Julius M. Liptak, Chris Wood, Shelly Shamir, Claire Rosenbaum, Vincenzo Montinaro, Brandan Wustefeld‐Janssens, Allyson Sterman, Colin Chik, Ameet Singh, Josh Collins, Laura E. Selmic. Risk factors and outcome in dogs with recurrent massive hepatocellular carcinoma: A Veterinary Society of Surgical Oncology case–control study Veterinary and Comparative Oncology 2022; 20(3): 697 doi: 10.1111/vco.12824
20
Yakun Wang, Lei Yang, Xichen Dong, Xin Yang, Xinxue Zhang, Zhe Liu, Xin Zhao, Tao Wen, Hui Yu. Overexpression of NNT-AS1 Activates TGF-β Signaling to Decrease Tumor CD4 Lymphocyte Infiltration in Hepatocellular CarcinomaBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/8216541
21
Pu Wu, Jinyuan Shi, Wei Sun, Hao Zhang. The prognostic value of plasma complement factor B (CFB) in thyroid carcinomaBioengineered 2021; 12(2): 12854 doi: 10.1080/21655979.2021.2005745
22
X Liu, H Ren, H Guo, W Wang, N Zhao. Interleukin-35 has a tumor-promoting role in hepatocellular carcinomaClinical and Experimental Immunology 2021; 203(2): 219 doi: 10.1111/cei.13535
23
Mengqi Xin. Research and Treatment Progress of Capmatinib in Hepatocellular CarcinomaHighlights in Science, Engineering and Technology 2022; 8: 576 doi: 10.54097/hset.v8i.1217
24
Di Ma, Juan Wang, Lu Liu, Meiqi Chen, Zhiyong Wang. Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: a preclinical studyBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07447-3
25
Jia-Ren Wang, Rui-Ning Li, Chao-Yi Huang, Chang Hong, Qi-Mei Li, Lin Zeng, Jing-Zhe He, Cheng-Yi Hu, Hao Cui, Li Liu, Lu-Shan Xiao. Impact of antibiotics on the efficacy of immune checkpoint inhibitors in the treatment of primary liver cancerLiver Research 2022; 6(3): 175 doi: 10.1016/j.livres.2022.05.004
26
Wenxiong Xu, Yanlin Huang, Yongyu Mei, Yeqiong Zhang, Qiumin Luo, Shu Zhu, Liang Peng, Zhiliang Gao, Ying Liu, Jianguo Li. High Expression of POGK Predicts Poor Prognosis in Patients with Hepatocellular CarcinomaCurrent Oncology 2022; 29(11): 8650 doi: 10.3390/curroncol29110682
27
Yifei Dai, Weijie Qiang, Kequan Lin, Yu Gui, Xun Lan, Dong Wang. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinomaCancer Immunology, Immunotherapy 2021; 70(4): 967 doi: 10.1007/s00262-020-02743-0
28
Xuefeng Kan, Guanhui Zhou, Feng Zhang, Hongxiu Ji, David S Shin, Wayne Monsky, Chuansheng Zheng, Xiaoming Yang. Enhanced efficacy of direct immunochemotherapy for hepatic cancer with image-guided intratumoral radiofrequency hyperthermiaJournal for ImmunoTherapy of Cancer 2022; 10(11): e005619 doi: 10.1136/jitc-2022-005619
29
Wei Wang, Fan Pan, Xinrong Lin, Jiakai Yuan, Chunyu Tao, Rui Wang. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance AnalysisFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.907331
30
Wenge Dong, Yangyang Xie, Hai Huang. Prognostic Value of Cancer-Associated Fibroblast-Related Gene Signatures in Hepatocellular CarcinomaFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.884777
31
Yi Huang, Zhou Yu, Min Zheng, Xiaohong Yang, Honglan Huang, Lijin Zhao. Methylation‑associated inactivation of JPH3 and its effect on prognosis and cell biological function in HCCMolecular Medicine Reports 2022; 25(4) doi: 10.3892/mmr.2022.12640
32
Jinlong Liang, Jingyi Wang, Jinshui Zeng, Zhibo Bai, Zhiyuan Zheng, Yue Zheng, Fengqi Jiang, Di Wu, Fu Wang. The Landscape of Early Growth Response Family Members 1-4 in Hepatocellular Carcinoma: Their Biological Roles and Diagnostic UtilityDisease Markers 2022; 2022: 1 doi: 10.1155/2022/3144742
33
Liyang Jia, Yanan Gao, Yaowu He, John D. Hooper, Pengyuan Yang. HBV induced hepatocellular carcinoma and related potential immunotherapyPharmacological Research 2020; 159: 104992 doi: 10.1016/j.phrs.2020.104992
34
Haichuan Wang, Yu Zhang, Li Yan, Qiang Lv, Jie Lu, Bei Yun. Analysis of TRIM27 prognosis value and immune infiltrates in hepatocellular carcinomaInternational Journal of Immunopathology and Pharmacology 2022; 36: 039463202211329 doi: 10.1177/03946320221132986
35
Hao Liang, Mingxing Xu, Zhiyong Xiong, Kunpeng Hu, Jiarui Yang, Mingbo Cao, Zhaozhong Zhong, Zhicheng Yao, Meihai Deng, Bo Liu. Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinomaAging 2021; 13(4): 6115 doi: 10.18632/aging.202606
36
Kai Tan, Kunlei Wang, Anbang Zhao, Zhicheng Liu, Wenjing Song, Qian Cheng, Xinyin Li, Zhinan Chen, Yufeng Yuan, Zhiyong Yang. Meiotic nuclear divisions 1 promotes proliferation and metastasis in hepatocellular carcinoma and is a potential diagnostic and therapeutic target geneMedical Oncology 2022; 40(1) doi: 10.1007/s12032-022-01875-w
37
Liwei Sun, Xuelong Xu, Fanguang Meng, Qian Liu, Hankang Wang, Xiaodong Li, Guijie Li, Feng Chen. Lenvatinib plus transarterial chemoembolization with or without immune checkpoint inhibitors for unresectable hepatocellular carcinoma: A reviewFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.980214
38
Lei Cao, Yu-Qin Zhu, Zhi-Xian Wu, Gao-Xiong Wang, Hong-Wei Cheng. Engineering nanotheranostic strategies for liver cancerWorld Journal of Gastrointestinal Oncology 2021; 13(10): 1213-1228 doi: 10.4251/wjgo.v13.i10.1213
39
Xi Wang, Xuchen Zhang. Hepatocellular adenoma: Where are we now?World Journal of Gastroenterology 2022; 28(14): 1384-1393 doi: 10.3748/wjg.v28.i14.1384
40
Xin Li, Jiahua Xu, Xiaoqiang Gu, Ling Chen, Qing Wu, Hongwei Li, Haoran Bai, Jinzu Yang, Jianxin Qian. Case Report: Antiangiogenic Therapy Plus Immune Checkpoint Inhibitors Combined With Intratumoral Cryoablation for Hepatocellular CarcinomaFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.740790
41
Xiaobin Fei, Songbai Liu, Peng Liu, Xing Wang, Changhao Zhu, Junyi Hou, Junzhe Cai, Yaozhen Pan. Identification and validation of a potential key gene SGOL1 for poor prognosis in hepatocellular carcinoma based on a bioinformatics approachFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1043161
42
Dan Chen, Xiaoting Li, Hui Li, Kai Wang, Xianghua Tian, Jimei Wang. Identification of Immune-Related Prognostic mRNA and lncRNA in Patients with Hepatocellular CarcinomaJournal of Oncology 2022; 2022: 1 doi: 10.1155/2022/5313149
43
Youpeng Wang, Yeni Yang, Ziyin Zhao, Hongfa Sun, Dingan Luo, Lakshmi Huttad, Bingyuan Zhang, Bing Han. A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cellsBMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09465-9
44
Nesil Yalman. LMCD1 antisense RNA 1 is a newly identified long noncoding RNAAnti-Cancer Drugs 2022; 33(1): 1 doi: 10.1097/CAD.0000000000001124
45
Raheleh Roudi, Alberto D'Angelo, Marianna Sirico, Navid Sobhani. Immunotherapeutic treatments in hepatocellular carcinoma; achievements, challenges and future prospectsInternational Immunopharmacology 2021; 101: 108322 doi: 10.1016/j.intimp.2021.108322
46
Nuray Üremiş, Muhammed Mehdi Üremiş, Yılmaz Çiğremiş, Emir Tosun, Ahmet Baysar, Yusuf Türköz. Cucurbitacin I exhibits anticancer efficacy through induction of apoptosis and modulation of JAK / STAT3 , MAPK / ERK , and AKT / mTOR signaling pathways in HepG2 cell line Journal of Food Biochemistry 2022; 46(10) doi: 10.1111/jfbc.14333
47
Zhou Lu, Ronghua Liu, Yining Wang, Mengxia Jiao, Zhongchen Li, Zhiqiang Wang, Cheng Huang, Guoming Shi, Aiwu Ke, Luman Wang, Ying Fu, Jie Xia, Haoyu Wen, Jian Zhou, Xiaoying Wang, Dan Ye, Jia Fan, Yiwei Chu, Jiabin Cai. Ten‐eleven translocation‐2 inactivation restrains IL‐10‐producing regulatory B cells to enable antitumor immunity in hepatocellular carcinomaHepatology 2022;  doi: 10.1002/hep.32442
48
Yagmur Azbazdar, Mustafa Karabicici, Esra Erdal, Gunes Ozhan. Regulation of Wnt Signaling Pathways at the Plasma Membrane and Their Misregulation in CancerFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.631623
49
Li Peng, Qi Yan, Zhaolin Chen, Ying Hu, Yuansong Sun, Yu Miao, Yincui Wu, Yan Yao, Liangsong Tao, Fei Chen, He Li, Tao Xu. Research progress on the role of cholesterol in hepatocellular carcinomaEuropean Journal of Pharmacology 2023; 938: 175410 doi: 10.1016/j.ejphar.2022.175410